Adipose Kp Prediction Across Lipophilicity

Why Adipose \(K_p\) Changes With Lipophilicity

Adipose tissue is unusual among tissues used in PBPK models because it contains a large neutral-lipid fraction. A compound that partitions weakly into lipid may have little adipose accumulation, even when the tissue contains abundant fat. As partitioning into neutral lipid strengthens, that phase can become the main contributor to the tissue concentration. The plasma concentration used as the denominator matters too: plasma lipids and protein binding can affect the total plasma concentration against which adipose is compared.

This tutorial develops a phase-composition calculation for neutral compounds and uses hypothetical examples to show how the estimate changes across lipophilicity. Here, \(K_p\) means the equilibrium ratio of total drug concentration in adipose tissue to total drug concentration in plasma, expressed on the same volume basis. LogP is the base-10 logarithm of the octanol-to-water partition coefficient for a neutral compound. It indicates lipophilicity, but it does not, by itself, supply an exact adipose neutral-lipid partition coefficient.

Deriving the Phase-Composition Expression

The expression follows from adding the amount of drug in each phase. At equilibrium, a neutral drug’s concentration in a tissue phase is its aqueous concentration multiplied by that phase’s partition coefficient. If the aqueous concentration in adipose is \(C_{a,w}\), then the concentration in adipose neutral lipid is \(P_{NL/w}C_{a,w}\); the phospholipid concentration is \(P_{PL/w}C_{a,w}\). Multiplying each phase concentration by its volume fraction and adding gives the total adipose concentration per unit tissue volume:

The same accounting applies to plasma. In this model, plasma protein association is included as a separate term, \(B_pC_{p,w}\), where \(C_{p,w}\) is the free aqueous plasma concentration. Thus,

At equilibrium, the free aqueous concentration used to describe the tissue phases is the same as that in plasma. Dividing \(C_a\) by \(C_p\) cancels that shared concentration and yields the stated \(K_p\) equation. This derivation is a phase-capacity balance: each term represents how much drug a phase holds per unit free aqueous concentration.

Worked Estimates Across Lipophilicity

The following examples use the same hypothetical adipose and plasma composition to isolate the effect of changing phase partition coefficients. The values are illustrative inputs, not universal physiological constants. In particular, the phase coefficients are supplied directly; they are not calculated by setting a phase partition coefficient equal to \(10^{\log P}\).

When Does Neutral Lipid Dominate?

A direct criterion can be obtained by comparing the neutral-lipid contribution to the other terms in the adipose numerator. Neutral lipid contributes more than half of that capacity precisely when its term exceeds the sum of the water and phospholipid terms:

For the example composition, this becomes \(0.75P_{NL/w}>0.20+0.05P_{PL/w}\). The criterion depends on both the amount of neutral lipid and the drug’s partitioning into the phases. A large \(f_{a,NL}\) alone is not enough.

Practical Checks, Alternatives, and Limitations

A useful diagnostic is to inspect the numerator and denominator separately before interpreting the final \(K_p\). Confirm that the phase fractions are plausible and use a consistent volume basis. Then calculate the contribution of each phase, rather than concluding that lipid dominates just because the compound has a high logP. Check that the partition coefficients refer to the phases represented in the equation and that plasma binding is treated consistently. A very large result should prompt a check of the inputs and arithmetic, particularly whether plasma lipid contributions were omitted.

The phase-composition method makes its assumptions visible and connects the estimate to measurable tissue composition. An empirical relationship between lipophilicity and \(K_p\) can be simpler to apply, but may obscure which phase drives a prediction and may not transfer well beyond the compounds and data used to fit it. A measured equilibrium \(K_p\) can avoid some prediction assumptions for the specific experimental conditions, but it depends on the quality and relevance of those measurements. These approaches answer related but not identical questions: a mechanistic estimate explains a proposed partitioning basis, while an empirical or measured value may better represent a particular data set.

The calculation is most directly interpretable for neutral compounds under the stated equilibrium assumptions. For an ionizable compound, the neutral species may still contribute to phase partitioning, but applying this neutral-only calculation as the complete model can miss ionization-dependent contributions. Likewise, real adipose composition varies, and the assumed phases do not capture every possible interaction or experimental complication. The equation should therefore be used as a structured estimate, with its inputs and scope reported, rather than as a universal conversion from logP to adipose \(K_p\).